Danielle Coppola

Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia

Joris Berwaerts, Yanning Liu, Srihari Gopal et al. · JAMA Psychiatry · 2015 · 224 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia

Danielle Coppola, Yanning Liu, Srihari Gopal et al. · BMC Psychiatry · 2012 · 60 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Exposure to Infliximab During Pregnancy: Post-Marketing Experience

Anja Geldhof, J. H. Slater, Michael B. Clark et al. · Drug Safety · 2019 · 34 citations · Full text

Public Health, Maternal Health, Obstetrics +11

A Post-hoc comparison of paliperidone palmitate to oral risperidone during initiation of long-acting risperidone injection in patients with acute schizophrenia.

Srihari Gopal, Gahan Pandina, Rosanne Lane et al. · PubMed · 2011 · 19 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Drug‐Drug Interaction Studies of Paliperidone and Divalproex Sodium Extended‐Release Tablets in Healthy Participants and Patients with Psychiatric Disorders

Bart Remmerie, Jay Ariyawansa, Marc De Meulder et al. · The Journal of Clinical Pharmacology · 2015 · 17 citations

Medicine, Pharmacology, Psychiatry +14